Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 16

1.

Differential expression of MART-1, tyrosinase, and SM5-1 in primary and metastatic melanoma.

Reinke S, Königer P, Herberth G, Audring H, Wang H, Ma J, Guo Y, Sterry W, Trefzer U.

Am J Dermatopathol. 2005 Oct;27(5):401-6.

PMID:
16148409
2.

Melan-A, a new melanocytic differentiation marker.

Busam KJ, Jungbluth AA.

Adv Anat Pathol. 1999 Jan;6(1):12-8. Review.

PMID:
10197235
3.

Expression of CALLA/CD10 on human melanoma cells.

Carrel S, Zografos L, Schreyer M, Rimoldi D.

Melanoma Res. 1993 Oct;3(5):319-23. Review.

PMID:
8292887
4.
5.

Immunohistochemistry as a diagnostic aid in the evaluation of ovarian tumors.

McCluggage WG, Young RH.

Semin Diagn Pathol. 2005 Feb;22(1):3-32. Review.

PMID:
16512597
6.

Unusual variants of malignant melanoma.

Magro CM, Crowson AN, Mihm MC.

Mod Pathol. 2006 Feb;19 Suppl 2:S41-70. Review.

7.

Immunohistochemical characteristics of melanoma.

Ohsie SJ, Sarantopoulos GP, Cochran AJ, Binder SW.

J Cutan Pathol. 2008 May;35(5):433-44. doi: 10.1111/j.1600-0560.2007.00891.x. Review.

PMID:
18399807
8.

Tumor cell and circulating markers in melanoma: diagnosis, prognosis, and management.

Kounalakis N, Goydos JS.

Curr Oncol Rep. 2005 Sep;7(5):377-82. Review.

PMID:
16091200
9.

False-positive cells in sentinel lymph nodes.

Brennick JB, Yan S.

Semin Diagn Pathol. 2008 May;25(2):116-9. Review.

PMID:
18697715
10.
11.

Value of melanocytic-associated immunohistochemical markers in the diagnosis of malignant melanoma: a review and update.

Ordóñez NG.

Hum Pathol. 2014 Feb;45(2):191-205. doi: 10.1016/j.humpath.2013.02.007. Epub 2013 May 3. Review.

PMID:
23648379
12.
13.

Primary malignant melanoma of the esophagus.

Joob AW, Haines GK 3rd, Kies MS, Shields TW.

Ann Thorac Surg. 1995 Jul;60(1):217-22. Review.

PMID:
7598604
14.

[Simultaneous occurrence of breast cancer, causing disseminated metastases after 32 years verified by immunohistochemistry, and cured malignant melanoma].

Nádasdy T, Gyöngyösy M, Krenács T.

Orv Hetil. 1988 Dec 18;129(51):2743-6. Review. Hungarian. No abstract available.

PMID:
3064024
15.

Native and genetically engineered anti-disialoganglioside monoclonal antibody treatment of melanoma.

Albertini MR, Hank JA, Sondel PM.

Cancer Chemother Biol Response Modif. 2005;22:789-97. Review. No abstract available.

PMID:
16110641
16.

[Anti-cytoskeleton antibodies and their value in cutaneous histopathology].

Kanitakis J.

Ann Dermatol Venereol. 1989;116(5):431-6. Review. French. No abstract available.

PMID:
2675739

Supplemental Content

Support Center